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In Malaysia, breast cancer is the most common cancer where 1 in 19 
Malaysian women will be diagnosed with breast cancer by the age of 85. Moreover, 
lack of specific symptoms in the early stage of disease leading to delay in diagnosis. 
Unfortunately, current treatments by chemotherapeutic agents, surgery and radiation 
are not fully effective for the treatment of breast cancer. Thus, there is an urgency in 
developing new approaches for the treatment of breast cancer patients. In this study, 
a novel therapeutic regimen, combining the effects of recombinant adenovirus and 
hyperthermia was investigated. Firstly, Adenovirus serotype 5 was constructed by 
cloning of p53 gene into a defective recombinant adenovirus vector, Ad5-p53-DsRed 
Monomer N1. The Ad5-p53-DsRed Monomer N1 (MOI of 100) was then used to 
infect breast cancer cells (MDA-MB 231 and MCF-7) with or without combination 
of hyperthermia treatment (42ºC for 2 hours). The cell killing and viral concentration 
were then determined by MTT assay and viral plaque formation assay respectively. 
After that, the heat shock protein (Hsp70) and p53 protein expression in transfected 
cells were quantitated using ELISA assay. Activated-Caspase 3/7, 8 and 9 were also 
evaluated to study the apoptotic pathway of cancer cells. Furthermore, the novel 
protein interaction between nucleotide binding domain (NBD) Hsp70 and human 
Ad5 E1A 32 kDa motif (PNLVP); and NBD and p53 motif (SCMGGMNR) were 
investigated through bioinformatics tools such as Gromacs and Autodock softwares. 
It was found that MDA-MB 231 and MCF-7 cells infected with virus Ad5-p53-
DsRed Monomer N1 alone resulted in 46.77±2.74% and 42.26±1.78% cell killing 
respectively while hyperthermia in combination with virus were 84.82±1.64% and 
80.13±3.30% respectively. The Hsp70 expression of both cancer cells was also 
increased to 170.57% (MDA-MB 231) and 169.83% (MCF-7). Moreover, p53 
expression in MDA-MB 231 and MCF-7 cells by virus combined with heat treatment 
(85.72 ng/L and 79.05 ng/L respectively) could lead to enhanced oncolytic property 
compared to virus treatment alone (47.82 ng/L and 40.54 ng/L respectively). In 
addition, caspase activity was first time reported that apoptosis process started at 
very early stage of infection in breast cancer cells with hyperthermia compared to 
virus alone. This was due to the evident that the highest kinetic energy was found in 
caspase 3 whereas virus alone the highest in caspase 8.  In conclusion, Hsp70 
induction by hyperthermia treatment enhanced Ad5-p53-DsRed Monomer N1 
replication and oncolysis in MDA-MB 231 and MCF-7 cells through apoptotic 
pathway. Besides that, NBD of Hsp70 had the best interaction with PNLVP motif at 
42°C. Thus, combining Ad5-p53 with hyperthermia treatment could be a potential 


















Di Malaysia, kanser payudara adalah kanser yang paling umum dimana 1 
dalam 19 wanita Malaysia akan didiagnosis dengan kanser payudara menjelang usia 
85. Tambahan pula, kekurangan tanda-tanda spesifik di peringkat awal penyakit yang 
membawa kepada kelewatan dalam diagnosis. Malangnya, rawatan semasa dengan 
agen kemoterapi, pembedahan dan radiasi tidak berkesan sepenuhnya untuk merawat 
kanser payudara. Oleh itu, strategi baru diperlukan dengan segera untuk merawat 
pesakit kanser payudara. Dalam kajian ini, potensi untuk mengabungkan regimen 
terapeutik novel adenovirus rekombinan dan „hyperthermia‟ telah dikaji. 
Pertamanya, Adenovirus jenis 5 telah dibangunkan dengan pengklonan gen p53 ke 
dalam vektor adenovirus rekombinan, Ad5-p53-DsRed Monomer N1. Kepekatan 100 
PFU bagi Ad5-p53-DsRed Monomer N1 telah digunakan untuk menjangkiti sel-sel 
kanser payudara (MDA-MB 231 dan MCF-7) dengan atau tanpa digabungkan 
dengan rawatan hyperthermia (42ºC selama 2 jam). Kemudian, tahap kemusnahan sel 
dan kepekatan virus telah ditentukan dengan asai MTT dan asai pembentukan plak 
virus. Selepas itu, pengekspresan protein kejutan haba (Hsp70) dan p53 dalam sel 
telah dianalisis dengan menggunakan asai ELISA. „Caspase‟ teraktif  3/7, 8 dan 9 
juga telah dikaji untuk tapak jalan apoptosis sel kanser. Tambahan pula, interaksi 
protein novel di antara domain pengikat nukleotida (NBD) bagi Hsp70 dan motif 
Ad5 E1A 32 kDa (PNLVP); dan NBD dan motif p53 (SCMGGMNR) telah dikaji 
dengan kaedah bioinformatik seperti perisian Gromacs dan Autodock. Kajian ini 
menunjukkan bahawa MDA-MB 231 dan MCF-7 yang dijangkiti virus Ad5-p53-
DsRed Monomer N1 sahaja menyebabkan 46.77 ± 2.74% dan 42.26 ± 1.78% sel 
musnah manakala „hyperthermia‟ dengan virus adalah 84.82 ± 1.64% dan 80.13 ± 
3.30% masing-masing. Pengekspresan protein Hsp70 bagi kedua-dua sel kanser juga 
meningkat kepada 170.57% (MDA-MB 231) dan 169.83% (MCF-7). Selain itu, 
pengekspresan protein p53 dalam MDA-MB 231 and MCF-7 bagi gabungan virus 
dan „hyperthermia‟ adalah 85.72 ng/L dan 79.05 ng/L masing-masing manakala 
perlakuan virus sahaja adalah 47.82 ng/L dan 40.54 ng/L masing-masing. Aktiviti 
„caspase‟ telah dilaporkan kali pertamanya bahawa proses apoptotik bermula pada 
peringkat yang sangat awal bagi gabungan virus dan „hyperthermia‟  berbanding 
dengan virus sahaja. Ini dibuktikan melalui tenaga kinetik yang paling tinggi didapati 
dalam caspase 3 manakala virus sahaja yang tertinggi dalam caspase 8. 
Kesimpulannya, induksi Hsp70 oleh perlakuan „hyperthermia‟  meningkatkan  
replikasi Ad5-p53-DsRed Monomer N1 dan „oncolysis‟ dalam sel MDA-MB 231 
dan MCF-7 melalui proses apoptotik. Selain itu, NBD bagi Hsp70 mempunyai 
interaksi yang terbaik dengan PNLVP motif pada 42°C. Oleh itu, penggabungan 
Ad5-p53 dengan „hyperthermia‟ mungkin boleh menjadi pendekatan bagi rawatan 
kanser payudara. 
 
 
